- Home
- Publications
- Publication Search
- Publication Details
Title
Epidrugs: targeting epigenetic marks in cancer treatment
Authors
Keywords
-
Journal
Epigenetics
Volume -, Issue -, Pages 1-13
Publisher
Informa UK Limited
Online
2019-07-06
DOI
10.1080/15592294.2019.1640546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting epigenetics for cancer therapy
- (2019) Jong Woo Park et al. ARCHIVES OF PHARMACAL RESEARCH
- Targeting Epigenetics in Cancer
- (2018) Richard L. Bennett et al. Annual Review of Pharmacology and Toxicology
- Long non-coding RNA-422 acts as a tumor suppressor in colorectal cancer
- (2018) Qianwen Shao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Unveiling epigenetic regulation in cancer, aging and rejuvenation with in vivo reprogramming technology
- (2018) Yuko Sogabe et al. CANCER SCIENCE
- Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
- (2018) Dauren Alimbetov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treating cancer with microRNA replacement therapy: A literature review
- (2018) Nayer Hosseinahli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application
- (2018) Yosuke YAMADA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Association between H3K4 methylation and cancer prognosis: A meta-analysis
- (2018) Simin Li et al. Thoracic Cancer
- Epigenetics and Epi-miRNAs: Potential markers/therapeutics in leukemia
- (2018) Fatemeh Memari et al. BIOMEDICINE & PHARMACOTHERAPY
- Monoclonal antibodies in cancer immunotherapy
- (2018) Ilgin Kimiz-Gebologlu et al. MOLECULAR BIOLOGY REPORTS
- Exploring the epigenetic drug discovery landscape
- (2017) Veda Prachayasittikul et al. Expert Opinion on Drug Discovery
- MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers
- (2017) Ammad Farooqi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2017) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- m6A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition
- (2017) Boxuan Simen Zhao et al. NATURE
- Drug development in the era of precision medicine
- (2017) Sarah A. Dugger et al. NATURE REVIEWS DRUG DISCOVERY
- The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
- (2017) Frank Lyko NATURE REVIEWS GENETICS
- Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
- (2017) Roberta Mazzone et al. Clinical Epigenetics
- Quorum Sensing Regulation of Competence and Bacteriocins in Streptococcus pneumoniae and mutans
- (2017) Erin Shanker et al. Genes
- Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
- (2017) Kentaro Inamura Cells
- A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes
- (2016) Zhaoyun Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cells
- (2016) Lubna Wasim et al. BIOMEDICINE & PHARMACOTHERAPY
- Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells
- (2016) Chun-Hao Pan et al. BMC CANCER
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
- (2016) Pedro Barata et al. CANCER TREATMENT REVIEWS
- Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
- (2016) Reza Salarinia et al. CURRENT CANCER DRUG TARGETS
- Circulating long non-coding RNAs in cancer: current status and future perspectives
- (2016) Peng Qi et al. Molecular Cancer
- DNA methylation on N6-adenine in mammalian embryonic stem cells
- (2016) Tao P. Wu et al. NATURE
- Targeting the cancer epigenome for therapy
- (2016) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
- (2016) Stephanie Kaypee et al. PHARMACOLOGY & THERAPEUTICS
- The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors
- (2016) Allen S Yang et al. Epigenomics
- Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine
- (2016) Mikkel Staberg et al. CELLULAR ONCOLOGY
- Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation
- (2016) Jiajia Chen et al. Journal of Cancer
- microRNA Therapeutics in Cancer — An Emerging Concept
- (2016) Maitri Y. Shah et al. EBioMedicine
- Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
- (2015) Krupa Shah et al. Anti-Cancer Agents in Medicinal Chemistry
- DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute myeloid leukemia who are ineligible for induction chemotherapy
- (2015) Olga Grishina et al. BMC CANCER
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Romidepsin for the treatment of non-Hodgkin’s lymphoma
- (2015) Victor Y Yazbeck et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation
- (2015) Shengdong Ke et al. GENES & DEVELOPMENT
- Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging
- (2015) Micah D. K. Glasgow et al. Journal of Biomedical Nanotechnology
- The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory
- (2015) Eli Raveh et al. Molecular Cancer
- Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
- (2015) S. P. Iyer et al. ONCOLOGIST
- Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy
- (2015) Sanchaika Gaur et al. Oncotarget
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
- (2015) Michael Christoph Haffner et al. Oncotarget
- Chromatin dynamics: Interplay between remodeling enzymes and histone modifications
- (2014) Sarah G. Swygert et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Changing Chromatin Fiber Conformation by Nucleosome Repositioning
- (2014) Oliver Müller et al. BIOPHYSICAL JOURNAL
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
- (2014) Bertrand Coiffier et al. Journal of Hematology & Oncology
- Global DNA hypomethylation in prostate cancer development and progression: a systematic review
- (2014) R Zelic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Long non-coding RNAs in cancer: implications for personalized therapy
- (2014) Marianna Vitiello et al. CELLULAR ONCOLOGY
- MicroRNAs as therapeutic targets in chemoresistance
- (2013) Michela Garofalo et al. DRUG RESISTANCE UPDATES
- Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis
- (2013) Keun Hur et al. GUT
- Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies
- (2013) Gerald S. Falchook et al. INVESTIGATIONAL NEW DRUGS
- Targeted intraoperative radiotherapy—one pit stop for breast cancer treatment
- (2013) Alessia Errico Nature Reviews Clinical Oncology
- A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells
- (2013) MIN FAN et al. Experimental and Therapeutic Medicine
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation
- (2012) Richard L. Momparler et al. LEUKEMIA RESEARCH
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
- (2012) Dan Dominissini et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer
- (2011) G. C. Hon et al. GENOME RESEARCH
- Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo
- (2011) Oscar Alcazar et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Prader-Willi syndrome and Angelman syndrome
- (2010) Karin Buiting AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- From protoplasmic theory to cellular systems biology: a 150-year reflection
- (2010) G. Rickey Welch et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Epigenetic cancer therapy: Proof of concept and remaining challenges
- (2010) Cora Mund et al. BIOESSAYS
- Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients
- (2010) B.-l. Liu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Epigenetics of imprinted long non-coding RNAs
- (2010) Faizaan Mohammad et al. Epigenetics
- Development of vorinostat: Current applications and future perspectives for cancer therapy
- (2009) Victoria M. Richon et al. CANCER LETTERS
- Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
- (2009) S. E. Elsheikh et al. CANCER RESEARCH
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
- (2009) M. T. Voso et al. CLINICAL CANCER RESEARCH
- Epigenetic Histone Code and Autoimmunity
- (2009) Jürgen Dieker et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Characterization of human epigenomes
- (2009) Zhibin Wang et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Imprinting evolution and human health
- (2009) Radhika Das et al. MAMMALIAN GENOME
- Maintenance of genomic methylation patterns during preimplantation development requires the somatic form of DNA methyltransferase 1
- (2007) Yukiko Kurihara et al. DEVELOPMENTAL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search